Comparison of Excipients in Approved Parenteral Products and Their Maximum Daily Exposure Values

References

1. 1.↵
   1. Katdare A.,
   2. Chaubal M. V.

   1. Bhattacharyyha L.,
   2. Schuber S.,
   3. Sheehan C.,
   4. William R.

   Excipients: Background/Introduction. In Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems; Katdare A., Chaubal M. V., Eds.; Informa Healthcare USA: New York, 2006; pp 1–3.
2. 2.↵
   1. Roy J.

   5—Formulated Drugs 1. In An Introduction to Pharmaceutical Sciences; Woodhead Publishing Series in Biomedicine; Woodhead Publishing: Cambridge, UK, 2011; pp 111–140.
3. 3.↵
   1. Apte S.,
   2. Ugwu S.

   A Review and Classification of Emerging Excipients in Parenteral Medications. Pharm. Technol. 2003, 27 (3), 46–60.

   OpenUrl
4. 4.↵
   1. Elder D.

   The Registration of Novel Excipients. Eur. Pharm. Rev. 2021, 26 (6), 5.

   OpenUrl
5. 5.↵
   1. Akers M. J.

   Excipient–Drug Interactions in Parenteral Formulations. J. Pharm. Sci. 2002, 91 (11), 2283–2300.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Nema S.,
   2. Brendel R. J.

   Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions. PDA J. Pharm. Sci. Technol. 2011, 65 (3), 287–332.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   U.S. Food and Drug Administration. Inactive Ingredients in Approved Drug Products Search: Frequently Asked Questions. https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-approved-drug-products-search-frequently-asked-questions (accessed June 24, 2022)
8. 8.↵
   1. Faunce T. A.,
   2. Johnston K.,
   3. Bambrick H.

   The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand, Victoria U. Victoria Univ. Wellington Law Rev. 2006, 37 (3), 365–390.

   OpenUrl
9. 9.↵
   1. Robinson J. K.,
   2. Sengelmann R. D.,
   3. Hanke C. W.,
   4. Siegel D. M.,
   5. Bhatia A. C.,
   6. Rohrer T. E.

   1. Weitzul S.,
   2. Taylor R. S.

   Chapter 16—Suturing Technique and Other Closure Materials. In Surgery of the Skin; Robinson J. K., Sengelmann R. D., Hanke C. W., Siegel D. M., Bhatia A. C., Rohrer T. E., Eds.; Mosby: St. Louis, MO, 2005; pp. 225-244
10. 10.↵
    1. Pramanick S.,
    2. Singodia D.,
    3. Chandel V.

    Excipient Selection in Parenteral Formulation Development. Pharmatimes 2013, 45 (3), 65–77.

    OpenUrl
11. 11.↵
    1. Mehmood Y.,
    2. Farooq U.

    Excipients Use in Parenteral and Lyophilized Formulation Development. Open Sci. J. Pharm. Pharmacol. 2015, 3 (3), 19–27.

    OpenUrl
12. 12.↵
    1. Rayaprolu B. M.,
    2. Strawser J. J.,
    3. Anyarambhatla G.

    Excipients in Parenteral Formulations: Selection Considerations and Effective Utilization with Small Molecules and Biologics. Drug Dev. Ind. Pharm. 2018, 44 (10), 1565–1571.

    OpenUrl
13. 13.↵
    1. Castañeda Ruiz A. J.,
    2. Shetab Boushehri M. A.,
    3. Phan T.,
    4. Carle S.,
    5. Garidel P.,
    6. Buske J.,
    7. Lamprecht A.

    Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates. Pharmaceutics 2022, 14 (12), 2575.

    OpenUrl
14. 14.↵
    1. Saito J.,
    2. Agrawal A.,
    3. Patravale V.,
    4. Pandya A.,
    5. Orubu S.,
    6. Zhao M.,
    7. Andrews G. P.,
    8. Petit-Turcotte C.,
    9. Landry H.,
    10. Croker A.,
    11. Nakamura H.,
    12. Yamatani A.,
    13. Salunke S.

    The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region. Children 2022, 9 (4), 453.

    OpenUrl
15. 15.↵
    1. Pifferi G.,
    2. Restani P.

    The Safety of Pharmaceutical Excipients. Il Farmaco 2003, 58 (8), 541–550.

    OpenUrl
16. 16.↵
    1. Osterberg R. E.,
    2. See N. A.

    Toxicity of Excipients—A Food and Drug Administration Perspective. Int. J. Toxicol. 2003, 22 (5), 377–380.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Rouaz K.,
    2. Chiclana-Rodríguez B.,
    3. Nardi-Ricart A.,
    4. Suñé-Pou M.,
    5. Mercadé-Frutos D.,
    6. Suñé-Negre J. M.,
    7. Pérez-Lozano P.,
    8. García-Montoya E.

    Excipients in the Paediatric Population: A Review. Pharmaceutics 2021, 13 (3), 387.

    OpenUrl